Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

A conversation about social media in Latin America

Gustavo Pratt takes a look at how healthcare companies in Mexico and Latin America can and should use social media, in line with our digital and social media focus month. Somewhere in Mexico City, 7:22 pm. Traffic is crazy, as it always is at this hour. It is your typical Wednesday in a big city in...

Articles

Tunnah’s musings: defining pharma thought leadership

With Spring finally in the air this month, Paul Tunnah muses on thought leadership within the pharma industry, why it is useful for engagement and exactly what it looks like. Thought leadership is a term that has seen increasing use across the business world recently, including within pharma. It is something I see as fundamental to way businesses…

Articles

Pharma Gets Social: Sanofi engages the diabetes online commu...

In our digital and social media focus month, Daniel Ghinn continues his series by looking at the engagement between Sanofi and the diabetes community on Twitter. While presenting a recent study into doctors talking about diabetes in public social media channels, I pointed out that among the...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital